Most sold healthcare stocks in Q4 2013
See which Healthcare stocks institutional investors trimmed or exited the most in Q4 2013, measured as net reductions in reported share positions from Q3 2013 into Q4 2013. Notable reductions at the top of this list include BOSTON SCIENTIFIC CORP (BSX), GRIFOLS SA-ADR (GRFS), DANAHER CORP (DHR), BRISTOL-MYERS SQUIBB CO (BMY). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| BSX | BOSTON SCIENTIFIC CORP | -13,671,149 | -$146.38M | 0 | 0 | 3 | 0 | 3 |
| GRFS | GRIFOLS SA-ADR | -5,245,452 | -$155.14M | 0 | 0 | 1 | 1 | 1 |
| DHR | DANAHER CORP | -4,993,674 | -$294.77M | 2 | 0 | 2 | 0 | 5 |
| BMY | BRISTOL-MYERS SQUIBB CO | -3,344,716 | -$144.89M | 2 | 0 | 4 | 0 | 8 |
| PHG | KONINKLIJKE PHILIPS NVR- NY | -2,477,292 | $66.37M | 0 | 0 | 3 | 0 | 3 |
| TMO | THERMO FISHER SCIENTIFIC INC | -1,963,714 | $178.33M | 1 | 1 | 5 | 1 | 8 |
| BAX | BAXTER INTERNATIONAL INC | -1,775,009 | -$93.06M | 1 | 3 | 4 | 0 | 9 |
| CORT | CORCEPT THERAPEUTICS INC | -1,504,100 | -$775.00K | 0 | 0 | 1 | 0 | 1 |
| MYGN | MYRIAD GENETICS INC | -1,420,839 | -$39.42M | 1 | 1 | 1 | 1 | 3 |
| WAT | WATERS CORP | -1,368,108 | -$165.45M | 1 | 0 | 2 | 2 | 3 |
| ZTS | ZOETIS INC | -1,308,974 | -$28.71M | 1 | 1 | 0 | 1 | 4 |
| LLY | ELI LILLY & CO | -1,221,857 | -$56.21M | 0 | 2 | 3 | 0 | 6 |
| UHS | UNIVERSAL HEALTH SERVICES-B | -1,074,916 | -$61.74M | 0 | 0 | 1 | 1 | 1 |
| MOH | MOLINA HEALTHCARE INC | -984,023 | -$35.44M | 0 | 0 | 1 | 0 | 1 |
| CAH | CARDINAL HEALTH INC | -829,764 | -$11.13M | 1 | 1 | 3 | 0 | 5 |
| CVS | CVS HEALTH CORP | -804,270 | $49.39M | 2 | 3 | 3 | 1 | 8 |
| A | AGILENT TECHNOLOGIES INC | -684,525 | $3.68M | 2 | 0 | 3 | 1 | 5 |
| BIIB | BIOGEN INC | -613,067 | -$122.78M | 1 | 0 | 1 | 1 | 4 |
| GERN | GERON CORP | -516,767 | $1.17M | 0 | 0 | 1 | 1 | 1 |
| COR | CENCORA INC | -470,000 | -$28.72M | 0 | 0 | 0 | 1 | 0 |
| MRK | MERCK & CO. INC. | -448,397 | $108.30M | 2 | 5 | 4 | 0 | 14 |
| ISRG | INTUITIVE SURGICAL INC | -447,276 | -$165.28M | 0 | 2 | 1 | 1 | 3 |
| PDCO | PATTERSON COS INC | -386,336 | -$6.82M | 1 | 3 | 1 | 0 | 5 |
| CRL | CHARLES RIVER LABORATORIES | -367,188 | $6.51M | 0 | 0 | 3 | 0 | 3 |
| MASI | MASIMO CORP | -297,862 | -$2.35M | 0 | 0 | 1 | 1 | 1 |
| PACB | PACIFIC BIOSCIENCES OF CALIF | -280,100 | -$1.55M | 0 | 0 | 0 | 1 | 0 |
| HUM | HUMANA INC | -270,961 | -$16.12M | 0 | 0 | 1 | 0 | 1 |
| VNDA | VANDA PHARMACEUTICALS INC | -256,600 | -$2.81M | 0 | 0 | 0 | 1 | 0 |
| OSUR | ORASURE TECHNOLOGIES INC | -243,099 | -$1.39M | 0 | 0 | 1 | 0 | 1 |
| UTHR | UNITED THERAPEUTICS CORP | -216,500 | -$9.39M | 0 | 0 | 1 | 0 | 1 |
| HAE | HAEMONETICS CORP/MASS | -210,400 | -$8.31M | 0 | 1 | 1 | 0 | 3 |
| ABBV | ABBVIE INC | -186,936 | $13.93M | 0 | 1 | 4 | 0 | 7 |
| THC | TENET HEALTHCARE CORP | -184,700 | -$7.55M | 0 | 0 | 1 | 0 | 1 |
| REGN | REGENERON PHARMACEUTICALS | -179,459 | -$58.85M | 0 | 0 | 1 | 0 | 2 |
| EW | EDWARDS LIFESCIENCES CORP | -169,527 | -$17.89M | 0 | 1 | 1 | 1 | 2 |
| PBH | PRESTIGE CONSUMER HEALTHCARE | -164,400 | $3.37M | 0 | 0 | 2 | 0 | 2 |
| ALKS | ALKERMES PLC | -156,100 | -$1.69M | 0 | 0 | 1 | 0 | 1 |
| CPRX | CATALYST PHARMACEUTICALS INC | -138,500 | -$422.00K | 0 | 0 | 0 | 1 | 0 |
| VRTX | VERTEX PHARMACEUTICALS INC | -130,910 | -$10.01M | 0 | 1 | 0 | 1 | 1 |
| HCA | HCA HEALTHCARE INC | -128,714 | $7.66M | 0 | 0 | 1 | 0 | 1 |
| ZBH | ZIMMER BIOMET HOLDINGS INC | -79,886 | $14.81M | 0 | 2 | 3 | 2 | 6 |
| CYH | COMMUNITY HEALTH SYSTEMS INC | -76,900 | -$4.05M | 0 | 0 | 1 | 0 | 1 |
| CNMD | CONMED CORP | -74,181 | -$2.52M | 0 | 0 | 0 | 1 | 0 |
| HCSG | HEALTHCARE SERVICES GROUP | -63,864 | -$1.61M | 1 | 0 | 0 | 1 | 1 |
| LAB | STANDARD BIOTOOLS INC | -55,000 | $115.00K | 0 | 0 | 1 | 0 | 1 |
| INCY | INCYTE CORP | -53,300 | -$1.59M | 0 | 0 | 1 | 1 | 1 |
| STAA | STAAR SURGICAL CO | -51,772 | -$616.00K | 0 | 0 | 1 | 0 | 1 |
| IDXX | IDEXX LABORATORIES INC | -40,149 | -$3.45M | 1 | 0 | 1 | 0 | 3 |
| JNJ | JOHNSON & JOHNSON | -40,077 | $136.19M | 2 | 10 | 8 | 0 | 23 |
| BIO | BIO-RAD LABORATORIES-A | -36,806 | $2.52M | 0 | 1 | 1 | 0 | 2 |
Frequently asked questions about Most sold healthcare stocks in Q4 2013
What are the most sold Healthcare stocks in Q4 2013?
The most sold healthcare stocks in Q4 2013 are those with the largest decrease in reported share counts across institutional investors compared to Q3 2013, based on SEC 13F filings.
Which healthcare stocks did institutional investors trimmed or exited the most in Q4 2013?
Among filers in this sector, net reductions were largest in companies such as BOSTON SCIENTIFIC CORP (BSX), GRIFOLS SA-ADR (GRFS), DANAHER CORP (DHR), based on aggregated 13F data.
How is institutional selling calculated?
Selling is calculated by summing the net decrease in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q3 2013).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.